Week46, 2020
1. Clinical labs reported 0.2% of respiratory specimens tested positive for influenza in week 46, with Influenza B (61%) circulating more than Influenza A (39%).
2. Public health labs found 6 positive specimens in week 46, the majority being Influenza A (85.7%), with limited subtype identification performed.
3. Nationwide outpatient ILI visits accounted for 1.5%, below the national baseline of 2.6%, with minimal to low ILI activity reported across jurisdictions.
4. 10.7% of deaths were attributed to pneumonia, influenza, and COVID-19 (PIC), primarily due to COVID-19, exceeding the epidemic threshold of 6.2%.
5. No pediatric influenza-associated deaths have been reported for the 2020â€“21 season.
6. Flu activity remains unusually low for this time of year, likely influenced by the COVID-19 pandemic.
7. Vaccinations are emphasized as the best defense against flu, with continued recommendations to get vaccinated immediately.
8. Reporting systems may be impacted by changes in healthcare-seeking behavior and overlap with COVID-19 symptoms, requiring cautious interpretation of ILI trends.
9. CDC anticipates potential increases in flu activity in the coming months.
10. Subtype analysis is limited due to a low number of positive specimens, and hospitalization rates remain unavailable for this season.